Dr. Bradley Monk graduated at the top of his class from the University of Arizona College of Medicine-Tucson in 1988 and completed a residency in Obstetrics and Gynecology at the University of California, Los Angeles, in 1992. In 1995, after three fellowships in Medical Genetics and Gynecologic Oncology, Dr. Monk was appointed director of gynecologic oncology at Texas Tech University Health Services Center and, from 1998 until 2010, was associate professor with tenure of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology at the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, and director of research in the Department of Obstetrics and Gynecology. Dr. Monk was then appointed director and professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, AZ. In 2016, he became a member of Arizona Oncology and part of the US Oncology Network. He was also appointed the US Oncology medical director of gynecologic oncology research. Dr. Monk is a fellow of the American College of Surgeons (ACS), the American College of Obstetricians and Gynecologists (ACOG), and the American Society for Colposcopy and Cervical Pathology (ASCCP), as well as being an active member of the Society of Gynecologic Oncology (SGO), American Society of Clinical Oncology (ASCO) and other professional organizations. He has authored more than 400 peer-reviewed articles along with more than 30 book chapters dealing predominantly with the prevention and chemotherapy of gynecologic malignancies and patient quality of life. He has led numerous clinical trials that have led to FDA approval of novel agents or changed the standard of care.